{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T07:14:09Z","timestamp":1695626049394},"reference-count":8,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A 37\u2010year\u2010old hemodialysis patient appeared with unusual somnolence during 2 successive hemodialysis sessions. Blood gas analysis revealed hypercapnic respiratory failure and spirometry restrictive lung disease. After exclusion of other causes of restrictive lung disease with chest CT\u2010scan and cerebrum MRI, electrophysiological study revealed myopathy. Because besides lordosis and limb\u2010girdle gait the patient was ambulant the possibility of late\u2010onset Pompe's disease was set and confirmed with evaluation of \u03b1\u2010glucosidase activity and genetic analysis. Enzyme replacement therapy (ERT) with aglucosidase alfa was started. Due to inaccessibility of veins in the arm without the arteriovenous fistula, during the last 1 year, the patient received the ERT through the venous line of the hemodialysis circuit. Three years later the patient remains ambulant without the need of any assistant device and preserved his pulmonary function. This is the first described case of late\u2010onset Pompe's disease in a hemodialysis patient treated with ERT.<\/jats:p>","DOI":"10.1111\/hdi.12617","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T15:52:40Z","timestamp":1507045960000},"source":"Crossref","is-referenced-by-count":0,"title":["Late\u2010onset Pompe's disease in a hemodialysis patient: A first case report"],"prefix":"10.1111","volume":"22","author":[{"given":"Theodoros","family":"Eleftheriadis","sequence":"first","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine University of Thessaly Larissa Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Makri","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine University of Thessaly Larissa Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paschalia","family":"Karakosta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine University of Thessaly Larissa Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Pissas","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine University of Thessaly Larissa Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Liakopoulos","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine University of Thessaly Larissa Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[{"name":"Department Enzymology and Cellular Function Institute of Child Health Athens Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios M.","family":"Hadjigeorgiou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine University of Thessaly Larissa Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Stefanidis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine University of Thessaly Larissa Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61555-X"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.12.009"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.06.002"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909859"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-34"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000165979.46537.56"},{"key":"e_1_2_7_8_1","unstructured":"LUMIZYME (Alglucosidase Alfa). Cambridge (MA): Genzyme Corporation;2010."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2007.00283.x"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhdi.12617","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hdi.12617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:00:47Z","timestamp":1695542447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hdi.12617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1111\/hdi.12617"],"URL":"https:\/\/doi.org\/10.1111\/hdi.12617","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}